{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:31:44Z","timestamp":1790011904676,"version":"4.0.1"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jns.2019.116620","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T11:51:28Z","timestamp":1575633088000},"page":"116620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Ophthalmological changes in hereditary spastic paraplegia and other genetic diseases with spastic paraplegia"],"prefix":"10.1016","volume":"409","author":[{"given":"J\u00falian Let\u00edcia","family":"de Freitas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio Moura","family":"Rezende Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana M.F.","family":"Sallum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Marcondes Cavalcante","family":"Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luiz","family":"Pedroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando G.P.","family":"Barsottini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2019.116620_bb0005","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/BF02224539","article-title":"XXXVI, Beitrage zur Pathologie des Ruckenmarks","volume":"10","author":"Strumpell","year":"1880","journal-title":"Arch. Psychiatr. Nervenkr."},{"key":"10.1016\/j.jns.2019.116620_bb0010","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S1474-4422(08)70258-8","article-title":"Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms","volume":"7","author":"Salinas","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2019.116620_bb0015","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(83)92879-9","article-title":"Classification of the hereditary ataxias and paraplegias","volume":"321","author":"Harding","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2019.116620_bb0020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000358801","article-title":"The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies","volume":"42","author":"Ruano","year":"2014","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jns.2019.116620_bb0025","series-title":"Chapter 77 \u2013 Hereditary Spastic Paraplegia","author":"Fink","year":"2015"},{"key":"10.1016\/j.jns.2019.116620_bb0030","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ajhg.2019.03.001","article-title":"Truncating mutations in UBAP1 cause hereditary spastic paraplegia","volume":"104","author":"Farazi Fard","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jns.2019.116620_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2012.03.025","article-title":"Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance","volume":"318","author":"Finsterer","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.116620_bb0040","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrneurol.2014.79","article-title":"Ophthalmic manifestations of inherited neurodegenerative disorders","volume":"10","author":"Kersten","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2019.116620_bb0045","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1212\/WNL.56.9.1230","article-title":"SPG15, a new locus for autosomal recessive complicated HSP on chromosome 14q","volume":"56","author":"Hughes","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.116620_bb0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archneur.1959.03840020007002","article-title":"Familial spastic paraplegia with amyotrophy, oligophrenia, and central retinal degeneration","volume":"1","author":"Kjellin","year":"1959","journal-title":"AMA Arch. Neurol."},{"key":"10.1016\/j.jns.2019.116620_bb0055","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/jnnp.63.5.628","article-title":"Two families with autosomal recessive spastic paraplegia, pigmented maculopathy, and dementia","volume":"63","author":"Webb","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.116620_bb0060","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ajhg.2008.03.004","article-title":"Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome","volume":"82","author":"Hanein","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jns.2019.116620_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/ICB.0b013e3181d5e942","article-title":"Characterization of kjellin syndrome using spectral-domain optical coherence tomography and fundus autofluorescence","volume":"5","author":"Tarantola","year":"2011","journal-title":"Retin. Cases Br. Rep."},{"key":"10.1016\/j.jns.2019.116620_bb0070","series-title":"Kjellin's Syndrome","first-page":"1484","article-title":"F. Autofluorescence","year":"2002"},{"key":"10.1016\/j.jns.2019.116620_bb0075","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5935\/0004-2749.20150031","article-title":"Macular dystrophy associated with Kjellin\u2019s syndrome: a case report","volume":"78","author":"de Castro","year":"2015","journal-title":"Arq. Bras. Oftalmol."},{"key":"10.1016\/j.jns.2019.116620_bb0080","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ophtha.2010.07.024","article-title":"Kjellin syndrome: long-term neuro-ophthalmologic follow-up and novel mutations in the SPG11 gene","volume":"118","author":"Puech","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jns.2019.116620_bb0085","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/acn3.64","article-title":"Lysosomal abnormalities in hereditary spastic paraplegia types SPG15 and SPG11","volume":"1","author":"Renvois\u00e9","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jns.2019.116620_bb0090","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1016\/j.celrep.2018.05.098","article-title":"Inhibition of lysosome membrane recycling causes accumulation of Gangliosides that contribute to neurodegeneration","volume":"23","author":"Boutry","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jns.2019.116620_bb0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2017.02.007","article-title":"Loss of spatacsin function alters lysosomal lipid clearance leading to upper and lower motor neuron degeneration","volume":"102","author":"Branchu","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jns.2019.116620_bb0100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.mcn.2011.04.004","article-title":"Cellular distribution and subcellular localization of spatacsin and spastizin, two proteins involved in hereditary spastic paraplegia","volume":"47","author":"Murmu","year":"2011","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.jns.2019.116620_bb0105","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0092-8674(00)81203-9","article-title":"Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease","volume":"93","author":"Casari","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.jns.2019.116620_bb0110","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/01.wnl.0000319700.11606.21","article-title":"Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes","volume":"71","author":"Brugman","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.116620_bb0115","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s00415-012-6792-z","article-title":"The p.Ala510Val mutation in the SPG7 (paraplegin) gene is the most common mutation causing adult onset neurogenetic disease in patients of British ancestry","volume":"260","author":"Roxburgh","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.116620_bb0120","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1212\/WNL.0000000000001369","article-title":"SPG7 mutations are a common cause of undiagnosed ataxia","volume":"84","author":"Pfeffer","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.116620_bb0125","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1212\/WNL.56.4.467","article-title":"Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England","volume":"56","author":"McDermott","year":"2001","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2019.116620_bb0130","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/brain\/awu060","article-title":"Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance","volume":"137","author":"Pfeffer","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jns.2019.116620_bb0135","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1212\/01.wnl.0000266667.91074.fe","article-title":"A novel form of autosomal recessive hereditary spastic paraplegia caused by a new SPG7 mutation","volume":"69","author":"Warnecke","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.116620_bb0140","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1093\/brain\/aws240","article-title":"Spastic paraplegia gene 7 in patients with spasticity and\/or optic neuropathy","volume":"135","author":"Klebe","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jns.2019.116620_bb0145","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1399-0004.2012.01896.x","article-title":"SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V","volume":"83","author":"S\u00e1nchez-Ferrero","year":"2013","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jns.2019.116620_bb0150","series-title":"Genotype \u2013 Phenotype Correlations in Spastic Paraplegia Type 7: A Study in a Large Dutch cohort","first-page":"2994","author":"Van Gassen","year":"2012"},{"key":"10.1016\/j.jns.2019.116620_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-12-143","article-title":"Retinal nerve fibre layer loss in hereditary spastic paraplegias is restricted to complex phenotypes","volume":"12","author":"Wiethoff","year":"2012","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jns.2019.116620_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbabio.2009.07.013","article-title":"Emerging roles of mitochondrial proteases in neurodegeneration","volume":"1797","author":"Martinelli","year":"2010","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.jns.2019.116620_bb0165","series-title":"Spastic Paraplegia, Optic Atrophy, and Neuropathy is Linked to Chromosome 11q13","first-page":"730","author":"Macedo-souza","year":"2005"},{"key":"10.1016\/j.jns.2019.116620_bb0170","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1469-1809.2009.00507.x","article-title":"Spastic paraplegia, optic atrophy, and neuropathy: new observations, locus refinement, and exclusion of candidate genes","volume":"73","author":"Macedo-Souza","year":"2009","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.jns.2019.116620_bb0175","series-title":"\u00a9 The Author 2015","first-page":"1","author":"Macedo-souza","year":"2015"},{"key":"10.1016\/j.jns.2019.116620_bb0180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/S0317167100024793","article-title":"Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS)","volume":"5","author":"Bouchard","year":"1978","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.116620_bb0185","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/72769","article-title":"ARSACS, a spastic ataxia common in northeastern Quebec, is caused by mutations in a new gene encoding an 11.5-kb ORF","volume":"24","author":"Engert","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jns.2019.116620_bb0190","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1096\/fj.201801556R","article-title":"Sacsin, mutated in the ataxia ARSACS, regulates intermediate filament assembly and dynamics","volume":"33","author":"Gentil","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.jns.2019.116620_bb0195","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.1113166109","article-title":"Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)","volume":"109","author":"Girard","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jns.2019.116620_bb0200","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/hmg\/ddu491","article-title":"Sacs knockout mice present pathophysiological defects underlying autosomal recessive spastic ataxia of Charlevoix-Saguenay","volume":"24","author":"Larivi\u00e8re","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jns.2019.116620_bb0205","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1212\/01.WNL.0000099371.14478.73","article-title":"Identification of a SACS gene missense mutation in ARSACS","volume":"62","author":"Ogawa","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.116620_bb0210","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.62.1.100","article-title":"A novel mutation in SACS gene in a family from southern Italy","volume":"62","author":"Criscuolo","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.116620_bb0215","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/mds.20579","article-title":"Novel mutation of SACS gene in a spanish family with autosomal recessive spastic ataxia","volume":"20","author":"Criscuolo","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2019.116620_bb0220","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10048-004-0179-y","article-title":"Private SACS mutations in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) families from Turkey","volume":"5","author":"Richter","year":"2004","journal-title":"Neurogenetics"},{"key":"10.1016\/j.jns.2019.116620_bb0225","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1001\/archneur.60.7.982","article-title":"Phenotypic features and genetic findings in sacsin-related autosomal recessive ataxia in Tunisia","volume":"60","author":"El Euch-Fayache","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2019.116620_bb0230","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10048-008-0131-7","article-title":"ARSACS in the Dutch population: a frequent cause of early-onset cerebellar ataxia","volume":"9","author":"Vermeer","year":"2008","journal-title":"Neurogenetics."},{"key":"10.1016\/j.jns.2019.116620_bb0235","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1212\/WNL.0b013e3181f4d86c","article-title":"Mutations in SACS cause atypical and late-onset forms of ARSACS","volume":"75","author":"Baets","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.116620_bb0240","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1590\/S0004-282X2011000300004","article-title":"Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS): typical clinical and neuroimaging features in a Brazilian family","volume":"69","author":"Pedroso","year":"2011","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.jns.2019.116620_bb0245","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-8-41","article-title":"Autosomal recessive spastic ataxia of Charlevoix Saguenay (ARSACS): expanding the genetic, clinical and imaging spectrum","volume":"8","author":"Synofzik","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2019.116620_bb0250","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jnnp-2012-303634","article-title":"The ARSACS phenotype can include supranuclear gaze palsy and skin lipofuscin deposits","volume":"84","author":"Stevens","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.116620_bb0255","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/ene.12220","article-title":"A novel SACS mutation results in non-ataxic spastic paraplegia and peripheral neuropathy","volume":"20","author":"Gregianin","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2019.116620_bb0260","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3174\/ajnr.A0603","article-title":"Autosomal recessive spastic ataxia of Charlevoix-Saguenay: a report of MR imaging in 5 patients","volume":"28","author":"Martin","year":"2007","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.jns.2019.116620_bb0265","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1468-1331.2012.03815.x","article-title":"Supratentorial and pontine MRI abnormalities characterize recessive spastic ataxia of Charlevoix-Saguenay. A comprehensive study of an Italian series","volume":"20","author":"Prodi","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2019.116620_bb0270","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp.2008.167528","article-title":"Frequency and phenotype of SPG11 and SPG15 in complicated hereditary spastic paraplegia","author":"Sch\u00fcle","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.116620_bb0275","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.parkreldis.2018.12.024","article-title":"Clinical, ophthalmological, imaging and genetic features in Brazilian patients with ARSACS","author":"Rezende Filho","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2019.116620_bb0280","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s12311-011-0286-x","article-title":"Thickening of peripapillar retinal fibers for the diagnosis of autosomal recessive spastic ataxia of Charlevoix-Saguenay","volume":"10","author":"Desserre","year":"2011","journal-title":"Cerebellum"},{"key":"10.1016\/j.jns.2019.116620_bb0285","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1468-1331.2010.03335.x","article-title":"Myelinated retinal fibers in autosomal recessive spastic ataxia of Charlevoix-Saguenay","volume":"18","author":"Vingolo","year":"2011","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2019.116620_bb0290","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/01658107.2011.595043","article-title":"Retinal imaging in autosomal recessive spastic ataxia of Charlevoix-Saguenay","volume":"35","author":"Nethisinghe","year":"2011","journal-title":"Neuro-Ophthalmology"},{"key":"10.1016\/j.jns.2019.116620_bb0295","first-page":"81","article-title":"Foveal hypoplasia in autosomal recessive spastic ataxia of Charlevoix-Saguenay","volume":"20","author":"Shah","year":"2016","journal-title":"JAAPOS"},{"key":"10.1016\/j.jns.2019.116620_bb0300","doi-asserted-by":"crossref","first-page":"7137","DOI":"10.1167\/iovs.13-12726","article-title":"Retinal segmentation as noninvasive technique to demonstrate hyperplasia in ataxia of Charlevoix-Saguenay","volume":"54","author":"Garcia-Martin","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jns.2019.116620_bb0305","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/brain\/awy028","article-title":"Optical coherence tomography in autosomal recessive spastic ataxia of Charlevoix-Saguenay","volume":"141","author":"Parkinson","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jns.2019.116620_bb0310","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jns.2016.09.023","article-title":"Retinal nerve fiber layer thickening in ARSACS carriers","volume":"370","author":"van Lint","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.116620_bb0315","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ejpn.2015.02.005","article-title":"Molecular and functional studies of retinal degeneration as a clinical presentation of SACS-related disorder","volume":"19","author":"Blumkin","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.jns.2019.116620_bb0320","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/bjophthalmol-2012-302309","article-title":"Retinal nerve fibre layer thickness in ARSACS: myelination or hypertrophy?","volume":"97","author":"Garcia-Martin","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jns.2019.116620_bb0325","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/bjophthalmol-2013-304534","article-title":"Abnormal retinal thickening is a common feature among patients with ARSACS-related phenotypes","volume":"98","author":"Yu-Wai-Man","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jns.2019.116620_bb0330","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fneur.2017.00523","article-title":"Inner retinal dysfunction in the autosomal recessive spastic ataxia of Charlevoix-Saguenay","volume":"8","author":"Borruat","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2019.116620_bb0335","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/361726a0","article-title":"Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters","volume":"361","author":"Mosser","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jns.2019.116620_bb0340","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archneur.1975.00490510033001","article-title":"Adrenoleukodystrophy: a clinical and pathological study of 17 cases","volume":"32","author":"Schaumburg","year":"1975","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2019.116620_bb0345","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1586\/14737175.8.9.1367","article-title":"Therapy of X-linked adrenoleukodystrophy","volume":"8","author":"Semmler","year":"2008","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.jns.2019.116620_bb0350","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/brain\/120.8.1485","article-title":"Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy","volume":"120","author":"Moser","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.jns.2019.116620_bb0355","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2000-9236","article-title":"X-linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients","volume":"31","author":"Moser","year":"2000","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jns.2019.116620_bb0360","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ncpneuro0421","article-title":"X-linked adrenoleukodystrophy","volume":"3","author":"Moser","year":"2007","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.jns.2019.116620_bb0365","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1212\/WNL.34.6.798","article-title":"Adrenoleukodystrophy: clinical and biochemical manifestations in carriers","volume":"34","author":"O\u2019Neill","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.116620_bb0370","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.410370419","article-title":"Visual system abnormalities in adrenomyeloneuropathy","volume":"37","author":"Kaplan","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2019.116620_bb0375","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0161-6420(87)33504-3","article-title":"Ophthalmologic manifestations of X-linked childhood Adrenoleulcodystrophy","volume":"94","author":"Traboulsi","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jns.2019.116620_bb0380","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.pediatrneurol.2013.04.012","article-title":"Pediatric neurology optical coherence tomography in X-linked adrenoleukodystrophy","volume":"49","author":"Aquino","year":"2013","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jns.2019.116620_bb0385","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/01658107.2014.950430","article-title":"Retinal ganglion cell loss in X-linked adrenoleukodystrophy with an ABCD1 mutation (Gly266Arg)","volume":"38","author":"Ohkuma","year":"2014","journal-title":"Neuro-Ophthalmology"},{"key":"10.1016\/j.jns.2019.116620_bb0390","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0161-6420(87)33345-7","article-title":"Ocular pathologic findings in neonatal adrenoleukodystrophy","volume":"94","author":"Glasgow","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jns.2019.116620_bb0395","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/bjo.2003.023010","article-title":"Leopard spot retinal pigmentation in infancy indicating a peroxisomal disorder","volume":"88","author":"Lyons","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jns.2019.116620_bb0400","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jamaophthalmol.2013.2089","article-title":"Interval spectral-domain optical coherence tomography and electrophysiology findings in neonatal Adrenoleukodystrophy","volume":"131","author":"Courtney","year":"2013","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.jns.2019.116620_bb0405","first-page":"794","article-title":"Color vision defects in adrenomyeloneuropathy","volume":"44","author":"Sack","year":"1989","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jns.2019.116620_bb0410","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jocn.2009.08.019","article-title":"Optic nerve atrophy in adrenoleukodystrophy detectable by optic coherence tomography","volume":"17","author":"Grainger","year":"2010","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2019.116620_bb0415","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/ICU.0000000000000314","article-title":"Dominant optic atrophy: updates on the pathophysiology and clinical manifestations of the optic atrophy 1 mutation","volume":"27","author":"Chun","year":"2016","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.jns.2019.116620_bb0420","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/brain\/awq007","article-title":"Multi-system neurological disease is common in patients with OPA1 mutations","volume":"133","author":"Yu-Wai-Man","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jns.2019.116620_bb0425","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jns.2011.12.002","article-title":"Optic atrophy plus phenotype due to mutations in the OPA1 gene: two more Italian families","volume":"315","author":"Ranieri","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.116620_bb0430","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/WNO.0000000000000068","article-title":"Optical coherence tomography and visual field findings in patients with friedreich Ataxia","volume":"34","author":"Da\u01e7","year":"2014","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.jns.2019.116620_bb0435","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12311-015-0755-8","article-title":"Nonneurological involvement in Late-Onset Friedreich Ataxia (LOFA): exploring the phenotypes","volume":"16","author":"Martinez","year":"2017","journal-title":"Cerebellum"},{"key":"10.1016\/j.jns.2019.116620_bb0440","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/ana.410410518","article-title":"Phenotypic variability in friedreich ataxia: role of the associated GAA triplet repeat expansion","volume":"41","author":"Montermini","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2019.116620_bb0445","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1212\/WNL.0000000000006086","article-title":"Child neurology: Friedreich ataxia with upper motor neuron findings","volume":"91","author":"Harvey","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.116620_bb0450","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/jnc.12317","article-title":"Clinical features of Friedreich\u2019s ataxia: classical and atypical phenotypes","volume":"126","author":"Parkinson","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jns.2019.116620_bb0455","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/eye.2011.291","article-title":"Ophthalmic features of Friedreich ataxia","volume":"26","author":"Noval","year":"2012","journal-title":"Eye"},{"key":"10.1016\/j.jns.2019.116620_bb0460","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/brain\/awn269","article-title":"Visual system involvement in patients with Friedreich\u2019s ataxia","volume":"132","author":"Fortuna","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.jns.2019.116620_bb0465","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-014-0179-4","article-title":"Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management","volume":"9","author":"Nie","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2019.116620_bb0470","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/gim.2013.28","article-title":"Hereditary ataxias: overview","volume":"15","author":"Jayadev","year":"2013","journal-title":"Genet. Med."},{"key":"10.1016\/j.jns.2019.116620_bb0475","series-title":"Natural History of Neurological Abnormalities in Cerebrotendinous Xanthomatosis","author":"Wong","year":"2018"},{"key":"10.1016\/j.jns.2019.116620_bb0480","series-title":"A Suspicion Index for Early Diagnosis and Treatment of Cerebrotendinous Xanthomatosis","author":"Mignarri","year":"2014"},{"key":"10.1016\/j.jns.2019.116620_bb0485","article-title":"Cerebrotendinous xanthomatosis: early diagnosis on the basis of juvenile cataracts","author":"Tibrewal","year":"2017","journal-title":"JAAPOS"},{"key":"10.1016\/j.jns.2019.116620_bb0490","series-title":"Prevalence of Cerebrotendinous Xanthomatosis Among Patients Diagnosed With Acquired Juvenile-Onset Idiopathic Bilateral Cataracts","first-page":"1","volume":"27710","author":"Freedman","year":"2019"},{"key":"10.1016\/j.jns.2019.116620_bb0495","first-page":"1","article-title":"Cerebrotendinous xanthomatosis - the spectrum of imaging findings","volume":"7","author":"Pudhiavan","year":"2013","journal-title":"J. Radiol. Case Rep."},{"key":"10.1016\/j.jns.2019.116620_bb0500","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1590\/0004-282X20160080","article-title":"A diagnostic approach for neurodegeneration with brain iron accumulation: clinical features, genetics and brain imaging","volume":"74","author":"Salom\u00e3o","year":"2016","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.jns.2019.116620_bb0505","series-title":"Rosenberg\u2019s Mol. Genet. Basis Neurol. Psychiatr. Dis","first-page":"473","article-title":"Pantothenate kinase-associated neurodegeneration","author":"Kruer","year":"2014"},{"key":"10.1016\/j.jns.2019.116620_bb0510","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/WNO.0000000000000335","article-title":"Optic atrophy in a patient with atypical pantothenate kinase-associated neurodegeneration","volume":"36","author":"Han","year":"2016","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.jns.2019.116620_bb0515","first-page":"1","article-title":"Visual and ocular motor function in the atypical form of neurodegeneration with brain iron accumulation type I","author":"Jesus-Ribeiro","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jns.2019.116620_bb0520","series-title":"Mitochondrial Membrane Protein-Associated Neurodegeneration (MPAN)","author":"Hartig","year":"2013"},{"key":"10.1016\/j.jns.2019.116620_bb0525","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/13554794.2016.1247458","article-title":"Clinical and imaging characteristics of late onset mitochondrial membrane protein-associated neurodegeneration (MPAN)","volume":"22","author":"Gore","year":"2016","journal-title":"Neurocase"},{"key":"10.1016\/j.jns.2019.116620_bb0530","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3174\/ajnr.A2677","article-title":"Neuroimaging features of neurodegeneration with brain iron accumulation","volume":"33","author":"Schneider","year":"2012","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.jns.2019.116620_bb0535","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/jhg.2015.3","article-title":"Novel mutations in the PNPLA6 gene in Boucher-Neuha\u00fcser syndrome","volume":"60","author":"Koh","year":"2015","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.jns.2019.116620_bb0540","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/brain\/awt326","article-title":"PNPLA6 mutations cause Boucher-Neuh\u00e4user and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum","volume":"137","author":"Synofzik","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.jns.2019.116620_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2018.06.016","article-title":"A new PNPLA6 mutation presenting as Oliver McFarlane syndrome","volume":"392","author":"Patsi","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.116620_bb0550","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/jnnp-2014-307793","article-title":"Ataxia meets chorioretinal dystrophy and hypogonadism:Boucher-Neuh\u00e4user syndrome due to PNPLA6 mutations","volume":"86","author":"Synofzik","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.116620_bb0555","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ajhg.2007.12.018","article-title":"Neuropathy target esterase gene mutations cause motor neuron disease","volume":"82","author":"Rainier","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jns.2019.116620_bb0560","first-page":"466","article-title":"A form of familial degeneration of the cerebellum","author":"Holmes","year":"1907","journal-title":"Brain"},{"key":"10.1016\/j.jns.2019.116620_bb0565","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1600-0404.1969.tb01261.x","article-title":"Familial ataxia, hypogonadism and retinal degeneration","volume":"45","author":"Boucher","year":"1969","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2019.116620_bb0570","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1399-0004.1975.tb00353.x","article-title":"Autosomal recessive syndrome of cerebellar ataxia and hypogonadotropic hypogonadism","author":"Neuh\u00e4user","year":"1975","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jns.2019.116620_bb0575","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10545-012-9518-6","article-title":"Sj\u00f6gren-Larsson syndrome in clinical practice","volume":"35","author":"Fuijkschot","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.jns.2019.116620_bb0580","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1399-0004.1981.tb00704.x","article-title":"Sjogren-Larsson syndrome in Sweden. A clinical, genetic and epidemiological study","volume":"19","author":"Jagell","year":"1981","journal-title":"Clin. Genet."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19323858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X19323858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:50:31Z","timestamp":1758383431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X19323858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":116,"alternative-id":["S0022510X19323858"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2019.116620","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ophthalmological changes in hereditary spastic paraplegia and other genetic diseases with spastic paraplegia","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2019.116620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116620"}}